The transaction is expected to close in the third quarter, after which Esperion will delist from the Nasdaq and operate as a privately held company.
LEO Pharma will gain access to Replay’s proprietary high-payload herpes simplex virus (HSV) delivery platform, an innovative technology designed to deliver large therapeutic genes directly into skin cells.
The collaboration focuses on multiple research programmes designed to develop and commercialise site-specific recombinases for diseases characterised by severe unmet medical needs.
The company expects the facility to increase production capacity and improve supply chain responsiveness across the Middle East and Africa (MEA).
The project received financial backing from First City Monument Bank (FCMB) and the Bank of Industry (BoI), reflecting a coordinated push to support local industry growth.
The AHLMC aims to provide strategic direction and accountability as Africa engages in key global processes, including the Pandemic Agreement, International Health Regulations discussions, UN80-linked reforms, and broader global health financing debates
LAUHS will manage the facility using its physician network, established medical protocols, and integrated healthcare model.
The initiative, dubbed “A Promise to Life,” reflects a shared commitment to ensuring safe deliveries and healthy starts for newborns.
CHG is currently the largest post-acute care provider in the Gulf Cooperation Council (GCC), with more than 700 beds across its network.